Back to top
more

Cabot (CBT)

(Delayed Data from NYSE)

$72.00 USD

72.00
734,837

-0.18 (-0.25%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $72.10 +0.10 (0.14%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Zacks Industry Outlook DuPont de Nemours, FMC and Cabot

by Zacks Equity Research

DuPont de Nemours, FMC and Cabot have been highlighted in this Industry Outlook article.

Zacks Equity Research

CBT vs. APD: Which Stock Is the Better Value Option?

by Zacks Equity Research

CBT vs. APD: Which Stock Is the Better Value Option?

Anindya Barman headshot

3 Diversified Chemical Stocks to Escape Industry Challenges

by Anindya Barman

Demand softness in specific markets and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. DD, FMC and CBT are poised to navigate the industry challenges.

Zacks Equity Research

Here's What Makes Cabot Stock a Solid Choice Right Now

by Zacks Equity Research

CBT benefits from robust demand across the automotive, infrastructure and semiconductor markets and improved product mix.

Zacks Equity Research

Here's Why You Should Add FMC Stock to Your Portfolio Now

by Zacks Equity Research

FMC gains on its efforts to expand its product portfolio through new product launches and restructuring and cost-reduction actions.

Zacks Equity Research

Here's Why You Should Retain Huntsman Stock in Your Portfolio

by Zacks Equity Research

While HUN faces headwinds from soft demand in certain markets, it gains on actions to grow its downstream specialty and formulation businesses and acquisitions.

Zacks Equity Research

Here's Why Cabot (CBT) is a Strong Momentum Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Cabot (CBT) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Cabot (CBT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Why Cabot (CBT) is a Top Value Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Is Cabot (CBT) Outperforming Other Basic Materials Stocks This Year?

by Zacks Equity Research

Here is how Cabot (CBT) and Hawkins (HWKN) have performed compared to their sector so far this year.

Zacks Equity Research

Should Value Investors Buy Cabot (CBT) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Cabot's Stock Rises 16% in Three Months: What's Driving the Rally?

by Zacks Equity Research

CBT's upside is fueled by strong segment performance, consistent earnings beats and an upbeat fiscal 2024 outlook.

Zacks Equity Research

Zacks.com featured highlights include NetApp, Cabot, Leidos, Charles River Associates and HCA Healthcare

by Zacks Equity Research

NetApp, Cabot, Leidos, Charles River Associates and HCA Healthcare are part of the Zacks Screen of the Week article.

Sweta Killa headshot

5 Dividend Growth Stocks Likely to Outperform Amid Low Rates

by Sweta Killa

NetApp, Cabot, Leidos Holdings, Charles River and HCA Healthcare could be compelling picks amid a low rate scenario.

Zacks Equity Research

Cabot Chosen for $50M Award Negotiation to Aid Battery Supply Chain

by Zacks Equity Research

The new manufacturing operation of CBT will boost the domestic supply chain for crucial battery ingredients, lowering dependency on foreign imports.

Zacks Equity Research

Cabot's Shares Reach Fresh 52-Week High: What's Driving It?

by Zacks Equity Research

CBT's shares hit a 52-week high, fueled by strong segment growth, higher earnings and an upbeat outlook on robust market demand.

Zacks Equity Research

Cabot Corporation (CBT) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Are Basic Materials Stocks Lagging Cabot (CBT) This Year?

by Zacks Equity Research

Here is how Cabot (CBT) and Vista Gold (VGZ) have performed compared to their sector so far this year.

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Cabot (CBT)

by Zacks Equity Research

Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Are Investors Undervaluing Cabot (CBT) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Zacks.com featured highlights include Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare

by Zacks Equity Research

Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare are part of the Zacks Screen of the Week article.

Zacks Equity Research

Cabot's Shares Rise 18% in Six Months: What's Driving the Stock?

by Zacks Equity Research

CBT's upside is fueled by strong segment performance, consistent earnings beat and an upbeat fiscal 2024 outlook.

Sweta Killa headshot

5 Dividend Growth Stocks to Buy in Historically Weak September

by Sweta Killa

Vertiv Holdings, Charles River, Cabot, Leidos Holdings and HCA Healthcare could be solid choices for a historically weak September.

Zacks Equity Research

Cabot (CBT) Down 0% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.